SC
AMGN icon

Scholtz & Company’s Amgen AMGN Stock Holding History

Scholtz & Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,030
Closed -$1.14M – 39
2015
Q4 		$1.14M Sell
7,030
-1,265
-15% -$199K 1.2% 31
2015
Q3 		$1.15M Sell
8,295
-75
-0.9% -$11.8K 1.23% 35
2015
Q2 		$1.28M Buy
8,370
+2,910
+53% +$466K 1.26% 30
2015
Q1 		$873K Buy
+5,460
New +$860K 0.84% 38

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Scholtz & Company's AMGN Position: Q1 2016 in Review

Scholtz & Company sold out of Amgen (AMGN) in Q1 2016, closing a stake of 7,030 shares — an estimated $1.14M sold.

Scholtz & Company first reported a position in AMGN in Q1 2015 and held it in 4 quarters. The position peaked at $1.28M in Q2 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Scholtz & Company reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Scholtz & Company sold 7,030 Amgen shares in Q1 2016, an estimated $1.14M.
  • Scholtz & Company first reported a position in Amgen in Q1 2015 and held it in 4 quarters.
  • Scholtz & Company's Amgen position peaked at $1.28M in Q2 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Scholtz & Company's 13F filing for Q1 2016, filed 16 May 2016.